Results per Page:
New horizons in infectious disease treatment and prevention in immunocompromised patients
The 5th Symposium on Infectious Disease in the Immunocompromised Host emphasized new opportunities, next generation
Pre-transplant microbiome sets the stage for GVHD
Preclinical findings highlight bacterial groups that influence GVHD risk
Nanoparticles open doors to cancer-fighting CAR T cells
Tiny liposome-based drug carriers make tumors more vulnerable to targeted immunotherapy
Single gene alters immune response to deadly brain cancer
A new study of glioma in humans and mice links more aggressive immune response to poorer prognosis
6 questions in cancer immunotherapy
From cancer vaccines to engineered T cells, experts weigh in on the big unknowns